1. Axelsen, Tobias M, Woldbye, David P D. . Gene Therapy for Parkinson's Disease, An Update. In Journal of Parkinson's disease, 8, 195-215. doi:10.3233/JPD-181331. https://pubmed.ncbi.nlm.nih.gov/29710735/
2. Man, Jing, Zhou, Wanbiao, Zuo, Shi, Ma, Huaxing, Li, Hai-Yang. 2023. TANGO1 interacts with NRTN to promote hepatocellular carcinoma progression by regulating the PI3K/AKT/mTOR signaling pathway. In Biochemical pharmacology, 213, 115615. doi:10.1016/j.bcp.2023.115615. https://pubmed.ncbi.nlm.nih.gov/37211171/
3. Tenenbaum, Liliane, Humbert-Claude, Marie. 2017. Glial Cell Line-Derived Neurotrophic Factor Gene Delivery in Parkinson's Disease: A Delicate Balance between Neuroprotection, Trophic Effects, and Unwanted Compensatory Mechanisms. In Frontiers in neuroanatomy, 11, 29. doi:10.3389/fnana.2017.00029. https://pubmed.ncbi.nlm.nih.gov/28442998/
4. Marks, William J, Baumann, Tiffany L, Bartus, Raymond T. 2016. Long-Term Safety of Patients with Parkinson's Disease Receiving rAAV2-Neurturin (CERE-120) Gene Transfer. In Human gene therapy, 27, 522-7. doi:10.1089/hum.2015.134. https://pubmed.ncbi.nlm.nih.gov/26711317/
5. Taşkan, Tuba, Noori, Farshad, Kurukahvecioğlu, Osman, Karaman, Niyazi, Gönenç, Aymelek. 2024. Neurturin gene IVSI-663 polymorphism but not RET variants is associated with increased risk for breast cancer. In Laboratory medicine, , . doi:10.1093/labmed/lmae097. https://pubmed.ncbi.nlm.nih.gov/39671698/
6. Wright, Christina M, Schneider, Sabine, Smith-Edwards, Kristen M, Davis, Brian M, Heuckeroth, Robert O. 2021. scRNA-Seq Reveals New Enteric Nervous System Roles for GDNF, NRTN, and TBX3. In Cellular and molecular gastroenterology and hepatology, 11, 1548-1592.e1. doi:10.1016/j.jcmgh.2020.12.014. https://pubmed.ncbi.nlm.nih.gov/33444816/
智鼠故事 
